Human collagen skin care product and preparation method thereof

By making human collagen into liposomes and combining other active ingredients, the problems of single and poor stability of existing anti-wrinkle skin care products have been solved, and multiple skin care effects and product stability have been improved.

CN119033620APending Publication Date: 2024-11-29GUANGDONG BOAN IND -ACADEMIC-RESEARCH COSMETICS CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411200684.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-29
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The existing anti-wrinkle skin care products have relatively single effects and are difficult to meet multiple needs. The use of recombinant human collagen has problems with immune rejection and stability.

Method used

By making human collagen into liposomes, combining photoglyceridine, grafted hyaluronic acid, rubag and sugar derivatives, special dispersants and preparation methods are used to improve the transdermal speed and penetration of collagen. , enhance antioxidant and whitening effects, and improve product stability and corrosion resistance through specific formulations and processes.

Benefits of technology

It achieves multiple effects such as anti-aging, whitening, moisturizing and repair, improves the stability and permeability of collagen, delays skin aging, and enhances the long-term stability and anti-corrosion effect of the product.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005017757590000061
    Figure BDA0005017757590000061
Patent Text Reader

Abstract

The invention relates to the field of cosmetics, and particularly discloses a human collagen skin care product and a preparation method thereof.The human collagen skin care product is prepared from, by weight, 0.1-0.3% of human collagen lipidosome, 0.05-0.15% of glabridin, 10-20% of humectant, 2-8% of saccharide derivatives, 5-10% of dispersing agent, 2-4% of 1, 2-propylene glycol and the balance deionized water, and the total weight percentage of the human collagen lipidosome, the glabridin, the humectant, the saccharide derivatives, the dispersing agent, the 1, 2-propylene glycol and the deionized water is 100%. Through synergistic effect of active substances and surface modification, the human collagen skin care product has the effects of resisting aging, whitening, moisturizing, repairing and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of cosmetics, and specifically relates to a human collagen skin care product and a preparation method thereof. Background Art

[0002] Collagen is the main structural component of the extracellular matrix, and the most common types in the skin are type I and type III collagen. As we age, collagen will inevitably be lost, resulting in a weakened support for the epidermis and the formation of wrinkles. Therefore, supplementing the skin with collagen can effectively slow down aging. Traditional animal-derived collagen may cause immune rejection when used. Recombinant human collagen produced by genetic engineering technology can reduce this reaction because it is closer to the body's own protein sequence. For example, patent CN 117598927B discloses an anti-wrinkle composition, an anti-wrinkle essence and a preparation method thereof, the components of which include recombinant collagen, ectoine, acetylated sodium hyaluronate, etc. The anti-wrinkle composition synergistically enhances the anti-aging effect, reduces the use of recombinant collagen active ingredients, and effectively reduces the investment cost, but its efficacy is relatively single and it is difficult to meet people's needs. Summary of the invention

[0003] In order to overcome the deficiencies of the prior art, the present invention provides a human collagen skin care product with anti-aging, whitening, moisturizing and repairing effects through the synergistic action of active substances and surface modification.

[0004] In order to achieve the above object, the technical solution adopted by the present invention is:

[0005] The first aspect of the present invention provides a human collagen skin care product, which comprises the following raw materials, based on the total weight percentage of 100%, human collagen liposome 0.1-0.3%, glabridin 0.05-0.15%, moisturizer 10-20%, carbohydrate derivative 2-8%, dispersant 5-10%, 1,2-propylene glycol 2-4%, and the balance is deionized water; wherein the moisturizer comprises grafted hyaluronic acid, glycerin and reed gum.

[0006] Preferably, the mass ratio of grafted hyaluronic acid, glycerin and lubricant gum in the moisturizer is (0.33-0.48):1:(0.26-0.37).

[0007] In some embodiments, the preparation steps of the grafted hyaluronic acid are as follows: dissolve hyaluronic acid in deionized water, add ferulic acid, vitamin C and hydrogen peroxide solution under nitrogen protection, stir at room temperature until no bubbles are generated, centrifuge to obtain the supernatant, and freeze-dry to obtain the grafted hyaluronic acid.

[0008] A large number of free radicals produced by human metabolism can cause oxidative damage to the body, leading to skin sagging, wrinkles and other phenomena. The present application improves the antioxidant effect of hyaluronic acid by grafting ferulic acid onto hyaluronic acid; and improves the problem of poor compatibility of ferulic acid with human collagen liposomes due to the short alkyl hydroxyl group of the molecule, so that it can exert its own strong antioxidant properties to achieve the function of delaying aging and skin whitening.

[0009] The lubricant has excellent moisturizing properties. Its unique cage structure makes it have the advantages of both water-soluble skin softeners and oily skin softeners, and has long-lasting water-locking ability. In this application, it can provide a lipid feel to improve the skin feel and lubricity of the product.

[0010] In some embodiments, the preparation steps of the human collagen liposomes are as follows:

[0011] S1. Dissolve lecithin and cholesterol in anhydrous ethanol, stir at 60-70° C. until the anhydrous ethanol is completely volatilized, and cool to 25-30° C. to obtain a mixture;

[0012] S2, stirring type III human collagen, Tween-80 and deionized water evenly, then adding them to the mixture of step S1, stirring for 20 to 40 minutes and then filtering to obtain the human collagen liposomes.

[0013] In some embodiments, the mass ratio of lecithin to cholesterol in step S1 is 1:(0.1-0.3).

[0014] Type III human collagen contains abundant hydrophilic amino acid residues, which are beneficial to the adhesion and proliferation of fibroblasts and can promote wound healing. However, as a biological macromolecule, it has poor stability and is not easy to penetrate the stratum corneum of the skin, and cannot exert its potential effect. For this reason, the present application prepares it into liposomes to improve the transdermal speed and penetration of type III human collagen; and the presence of its lipid layer also effectively alleviates the problems of poor solubility and chemical instability of glycyrrhizin, increases the amount of glycyrrhizin added in this system, and is beneficial to exerting the whitening effect of glycyrrhizin.

[0015] In some embodiments, the preparation steps of the dispersant are as follows: deionized water, dodecylphenol polyoxyethylene ether and sodium dodecyl sulfate are stirred evenly, and then the mixed monomer is added, and stirred at 70-80°C for 20-40 minutes, and then the initiator is added and stirred for 1-2 hours. After cooling to room temperature, the carboxymethyl chitosan solution is added, and the dispersant is obtained after stirring evenly.

[0016] In some embodiments, the mass ratio of the dodecylphenol polyoxyethylene ether to the mixed monomer is 1:(24-28.5).

[0017] In some embodiments, the mixed monomer comprises methyl methacrylate, butyl acrylate, and isooctyl acrylate.

[0018] In some embodiments, the mass ratio of methyl methacrylate, butyl acrylate and isooctyl acrylate is 1:(0.7-0.85):(0.65-0.83).

[0019] The dispersant of the present application is in the form of a nanoemulsion, which can make various active substances in the raw materials evenly dispersed in the system and maintain uniform stability for a long time; in addition, the chitosan used in the dispersant has certain antibacterial properties, which can promote the formation of the dispersant into a nano-solution state while also improving the antibacterial properties of the dispersant, so that the dispersant and 1,2-propylene glycol can synergistically exert an antiseptic effect; and the dispersant can also enhance the strength of the lipid layer in the human collagen liposome to prevent it from being damaged during the preparation process.

[0020] In some embodiments, the sugar derivative comprises glyceryl glucoside, xylitol glucoside and sorbitol.

[0021] In some embodiments, the mass ratio of the glycerol glucoside, xylitol glucoside and sorbitol is (0.36-0.55):(0.22-0.42):1.

[0022] Glycerol glucoside in sugar derivatives can activate type I collagen precursors in aging cells and increase skin elasticity; xylitol glucoside has an antioxidant effect, can neutralize free radicals, reduce free radical damage to the skin, and promote the production of hyaluronic acid, which helps to improve the skin's water retention; sorbitol has good water absorption, can effectively absorb moisture from the air and keep the skin moist. This application improves the transdermal absorption rate through specific compounding based on the efficacy of the above sugar derivatives.

[0023] The second aspect of the present invention provides a method for preparing a human collagen skin care product, comprising the following steps: stirring glycyrrhizin and a sugar derivative evenly, then adding a dispersant, 1,2-propylene glycol, human collagen liposomes and deionized water and homogenizing at a speed of 9000 to 11000 rpm for 50 to 70 seconds, then adding a moisturizer and continuing to homogenize for 25 to 35 seconds to obtain the human collagen skin care product.

[0024] Compared with the prior art, the present invention has the following beneficial effects:

[0025] The human collagen skin care product of the present invention has the effects of anti-aging, whitening, moisturizing and repairing. On the one hand, the transdermal speed and penetration amount of type III human collagen are improved by making type III human collagen into liposomes, and the lipid layer is used to effectively alleviate the problems of poor solubility and chemical instability of glycyrrhizin, thereby increasing the amount of glycyrrhizin added to the system; on the second hand, the antioxidant effect of hyaluronic acid is improved by using special hyaluronic acid, and the compatibility of ferulic acid and human collagen liposomes is increased; on the third hand, a special dispersant is used to maintain the long-term stability of various active substances in the raw materials. At the same time, the dispersant can also synergistically exert the preservative effect with 1,2-propylene glycol, and can enhance the strength of the lipid layer in the human collagen liposome to avoid damage to the human collagen liposome during the preparation process. DETAILED DESCRIPTION

[0026] The present invention will be described below in conjunction with specific embodiments. It should be noted that the following embodiments are examples of the present invention and are only used to illustrate the present invention, but not to limit the present invention. Other combinations and various modifications within the concept of the present invention may be performed without departing from the spirit or scope of the present invention.

[0027] In order to facilitate those skilled in the art to implement the present invention, some raw materials and manufacturers of the embodiments and comparative examples are described as follows:

[0028] Bloomcolla TM Recombinant humanized type III collagen was purchased from Bloomage Biotech Co., Ltd.;

[0029] Hyaluronic acid was purchased from Shandong Focus Freda Biological Co., Ltd. with a number average molecular weight of 30 kDa.

[0030] Preparation Example 1

[0031] The preparation steps of human collagen liposomes are as follows:

[0032] S1. Dissolve 1 g of lecithin and 0.2 g of cholesterol in 50 mL of anhydrous ethanol, stir at 65° C. until the anhydrous ethanol is completely evaporated, and cool to 26° C. to obtain a mixture;

[0033] S2, 0.5g Bloomcolla TM Recombinant type III collagen, 0.5 mL Tween-80 and 40 mL deionized water were mixed evenly, then added to the mixture in step S1, stirred for 30 minutes, and filtered through a 0.22 um microporous filter membrane to obtain human collagen liposomes.

[0034] Preparation Example 2

[0035] The preparation steps of dispersant-A are as follows:

[0036] 30g of deionized water, 1.5g of dodecylphenol polyoxyethylene ether and 0.5g of sodium dodecyl sulfate were stirred evenly, and then 16g of methyl methacrylate, 12g of butyl acrylate and 11.5g of isooctyl acrylate were added, and stirred at 75°C for 30min. Then 3.6g of ammonium persulfate was added and stirred for 1.5h. After cooling to room temperature, 8g of 1wt% carboxymethyl chitosan solution was added, and the mixture was stirred evenly to obtain dispersant-A.

[0037] Preparation Example 3

[0038] The preparation steps of dispersant-B are as follows:

[0039] The difference between this Preparation Example and Preparation Example 2 is that the amount of methyl methacrylate used is 13 g.

[0040] Preparation Example 4

[0041] The preparation steps of dispersant-C are as follows:

[0042] The difference between this Preparation Example and Preparation Example 2 is that the amount of methyl methacrylate used is 19 g.

[0043] Preparation Example 5

[0044] The preparation steps of grafted hyaluronic acid are as follows:

[0045] Dissolve 25 g of hyaluronic acid in 800 mL of deionized water, add 25 g of ferulic acid, 5 g of vitamin C and 50 mL of 2 mol / L hydrogen peroxide solution under nitrogen protection, stir at room temperature until no bubbles are generated, centrifuge at 10,000 rpm for 15 min, take the supernatant, and freeze-dry to obtain grafted hyaluronic acid.

[0046] Example 1

[0047] A human collagen skin care product, comprising the following raw materials, calculated by weight percentage, 0.2% human collagen liposome, 0.1% glabridin, 3.2wt% grafted hyaluronic acid, 9.3% glycerol, 2.5% lubricant gum, 1.2% glycerol glucoside, 0.9% xylitol glucoside and 2.9% sorbitol, 7% dispersant-A, 3% 1,2-propylene glycol, and 69.7% deionized water;

[0048] The preparation method of the human collagen skin care product in this embodiment comprises the following steps: evenly stirring glabridin, glycerol glucoside, xylitol glucoside and sorbitol, then adding dispersant-A, 1,2-propylene glycol, human collagen liposomes and deionized water, and homogenizing at a speed of 10000 rpm for 60 seconds, and then adding grafted hyaluronic acid, glycerol and linalool gum and continuing to homogenize for 30 seconds to obtain the human collagen skin care product.

[0049] Example 2

[0050] A human collagen skin care product, the total weight percentage is 100%, comprising the following raw materials: 0.1% human collagen liposome, 0.05% glabridin, 1.98wt% grafted hyaluronic acid, 6% glycerol, 2.02% lubricant gum, 0.45% glycerol glucoside, 0.29% xylitol glucoside and 1.26% sorbitol, 5% dispersant-A, 2% 1,2-propylene glycol, and 80.85% deionized water;

[0051] The preparation method of the human collagen skin care product in this embodiment comprises the following steps: evenly stirring glabridin, glycerol glucoside, xylitol glucoside and sorbitol, then adding dispersant-A, 1,2-propylene glycol, human collagen liposomes and deionized water, and homogenizing at a speed of 9000 rpm for 70 seconds, and then adding grafted hyaluronic acid, glycerol and argyi gum and continuing to homogenize for 25 seconds to obtain the human collagen skin care product.

[0052] Example 3

[0053] A human collagen skin care product, the total weight percentage is 100%, comprising the following raw materials: 0.3% human collagen liposome, 0.15% glabridin, 5.1wt% grafted hyaluronic acid, 11% glycerol, 3.9% lubricant gum, 2.2% glycerol glucoside, 1.7% xylitol glucoside and 4.1% sorbitol, 10% dispersant-A, 4% 1,2-propylene glycol, and 57.55% deionized water;

[0054] The preparation method of the human collagen skin care product in this embodiment comprises the following steps: evenly stirring glabridin, glycerol glucoside, xylitol glucoside and sorbitol, then adding dispersant-A, 1,2-propylene glycol, human collagen liposomes and deionized water, and homogenizing at a speed of 11000 rpm for 50 seconds, and then adding grafted hyaluronic acid, glycerol and argyi gum and continuing to homogenize for 35 seconds to obtain the human collagen skin care product.

[0055] Example 4

[0056] This embodiment provides a human collagen skin care product and a preparation method thereof. The specific implementation method is the same as that of Example 1, except that dispersant-A is replaced by an equal amount of dispersant-B.

[0057] Example 5

[0058] This embodiment provides a human collagen skin care product and a preparation method thereof. The specific implementation method is the same as that of Example 1, except that: dispersant-A is replaced by an equal amount of dispersant-C.

[0059] Example 6

[0060] This embodiment provides a human collagen skin care product and a preparation method thereof. The specific implementation method is the same as that of Example 1, except that the grafted hyaluronic acid is replaced by an equal amount of a mixture of hyaluronic acid and ferulic acid, wherein the mass ratio of hyaluronic acid to ferulic acid is 1:1.

[0061] Comparative Example 1

[0062] This comparative example provides a human collagen skin care product and a preparation method thereof. The specific implementation method is the same as that of Example 1, except that: the human collagen liposome is composed of the same amount of Bloomcolla TM Recombinant humanized type III collagen replacement.

[0063] Performance Test:

[0064] 1. Antioxidant effect test

[0065] 5 mL of ABTS with a concentration of 7 mmol / L + The solution was mixed with 88 μL of 140 mmol / L K2S2O8 solution, sealed and allowed to stand for 16 h, then diluted with anhydrous ethanol until the absorbance at 734 nm was 0.70 ± 0.02 to obtain ABTS + Working fluid;

[0066] Place 200 μL of ABTS + Working solution, add 10 μL of the human collagen skin care product provided in each example, incubate at 30°C in dark for 6 min, and measure the absorbance A at 734 nm s ;

[0067] Using distilled water as blank control, the absorbance was measured in the same way to obtain the absorbance A c ;

[0068] ABTS is calculated as follows + Clearance rate Q:

[0069]

[0070] 2. Storage stability test

[0071] The human collagen skin care products provided in each embodiment were placed at -10°C and 60°C for 10 days to observe whether there was stratification. The phenomenon was divided into three types: no stratification, stratification, and obvious stratification, and the stability decreased gradually.

[0072] 3. Wrinkle removal test

[0073] 36 volunteers aged 18 to 55 years old were selected, including 18 males and 18 females, and randomly divided into test groups 1 to 9, with 4 cases in each group. The skin care products provided in each embodiment were wiped on the face twice in the morning and evening. After 10 weeks, the wrinkle reduction before and after use was tested by Visia skin detector.

[0074] The results are shown in Table 1.

[0075] Table 1 Performance test results

[0076] Clearance rate Q / % Stratification Wrinkle reduction / % Example 1 97.2 No stratification 32.8 Example 2 95.8 No stratification 29.9 Example 3 96.4 No stratification 30.6 Example 4 87.7 Layered existence 24.9 Example 5 91.3 Layered existence 26.3 Example 6 83.7 Layered existence 23.1 Comparative Example 1 80.9 No stratification 20.5

[0077] From the data in Table 1, it can be seen that the human collagen skin care products of Examples 1 to 3 have good stability and good antioxidant and wrinkle removal capabilities. Compared with Example 1, Examples 4 to 5 changed the ratio of mixed monomers in the dispersant, hindering the formation of nanoemulsions, thereby affecting the stability of the system. The decrease in stability leads to the inability of the active substance to exert an ideal effect.

[0078] Compared with Example 1, in Example 6, hyaluronic acid and ferulic acid are directly added into the system, which results in poor compatibility of ferulic acid with human collagen liposomes, leading to decreased antioxidant effect.

[0079] Compared with Example 1, Comparative Example 1 does not prepare type III human collagen into liposomes, which is not conducive to the penetration of type III human collagen, resulting in a decrease in the wrinkle removal effect; and also affects the chemical stability of glycyrrhizin in this system, thereby resulting in a decrease in the antioxidant effect.

[0080] The embodiments and comparative examples described above do not impose any form of limitation on the present invention. Although the present invention has been disclosed as a preferred embodiment as above, it is not intended to limit the present invention. Any technician familiar with the profession can make some changes or modifications to equivalent embodiments of equivalent changes using the technical contents disclosed above without departing from the scope of the technical solution of the present invention. However, any simple modification, equivalent change and modification made to the above embodiments based on the technical essence of the present invention without departing from the content of the technical solution of the present invention still falls within the scope of the technical solution of the present invention.

Claims

1. A human collagen skin care product, characterized in that: The composition comprises the following raw materials, calculated on the basis of the total weight percentage of 100%, human collagen liposome 0.1-0.3%, glabridin 0.05-0.15%, moisturizer 10-20%, carbohydrate derivative 2-8%, dispersant 5-10%, 1,2-propylene glycol 2-4%, and the balance is deionized water; wherein the moisturizer comprises grafted hyaluronic acid, glycerin and reed gum.

2. The human collagen skin care product according to claim 1, characterized in that: The preparation steps of the human collagen liposomes are as follows: S1. Dissolve lecithin and cholesterol in anhydrous ethanol, stir at 60-70° C. until the anhydrous ethanol is completely volatilized, and cool to 25-30° C. to obtain a mixture; S2, stirring type III human collagen, Tween-80 and deionized water evenly, then adding them to the mixture of step S1, stirring for 20 to 40 minutes and then filtering to obtain the human collagen liposomes.

3. The human collagen skin care product according to claim 2, characterized in that: The mass ratio of lecithin to cholesterol in step S1 is 1:(0.1-0.3).

4. The human collagen skin care product according to claim 1, characterized in that: The preparation steps of the dispersant are as follows: deionized water, dodecylphenol polyoxyethylene ether and sodium dodecyl sulfate are stirred evenly, then mixed monomers are added, stirred at 70-80° C. for 20-40 minutes, then initiator is added and stirred for 1-2 hours, carboxymethyl chitosan solution is added after cooling to room temperature, and the dispersant is obtained after stirring evenly.

5. The human collagen skin care product according to claim 4, characterized in that: The mass ratio of the dodecylphenol polyoxyethylene ether to the mixed monomer is 1:(24-28.5).

6. The human collagen skin care product according to claim 5, characterized in that: The mixed monomer comprises methyl methacrylate, butyl acrylate and isooctyl acrylate.

7. The human collagen skin care product according to claim 6, characterized in that: The mass ratio of the methyl methacrylate, butyl acrylate and isooctyl acrylate is 1:(0.7-0.85):(0.65-0.83).

8. The human collagen skin care product according to claim 1, characterized in that: The sugar derivatives include glyceryl glucoside, xylitol glucoside and sorbitol.

9. The human collagen skin care product according to claim 8, characterized in that: The mass ratio of the glycerol glucoside, xylitol glucoside and sorbitol is (0.36-0.55):(0.22-0.42):

1.

10. A method for preparing the human collagen skin care product according to any one of claims 1 to 9, characterized in that: The preparation method comprises the following steps: stirring glabridin and a sugar derivative evenly, then adding a dispersant, 1,2-propylene glycol, human collagen liposomes and deionized water, and homogenizing at a speed of 9000 to 11000 rpm for 50 to 70 seconds, and then adding a moisturizer and continuing to homogenize for 25 to 35 seconds to obtain the human collagen skin care product.